Correlation Between Smithson Investment and ImmuPharma PLC
Can any of the company-specific risk be diversified away by investing in both Smithson Investment and ImmuPharma PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Smithson Investment and ImmuPharma PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Smithson Investment Trust and ImmuPharma PLC, you can compare the effects of market volatilities on Smithson Investment and ImmuPharma PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Smithson Investment with a short position of ImmuPharma PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Smithson Investment and ImmuPharma PLC.
Diversification Opportunities for Smithson Investment and ImmuPharma PLC
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Smithson and ImmuPharma is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Smithson Investment Trust and ImmuPharma PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ImmuPharma PLC and Smithson Investment is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Smithson Investment Trust are associated (or correlated) with ImmuPharma PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ImmuPharma PLC has no effect on the direction of Smithson Investment i.e., Smithson Investment and ImmuPharma PLC go up and down completely randomly.
Pair Corralation between Smithson Investment and ImmuPharma PLC
Assuming the 90 days trading horizon Smithson Investment Trust is expected to generate 0.24 times more return on investment than ImmuPharma PLC. However, Smithson Investment Trust is 4.14 times less risky than ImmuPharma PLC. It trades about 0.31 of its potential returns per unit of risk. ImmuPharma PLC is currently generating about -0.29 per unit of risk. If you would invest 140,200 in Smithson Investment Trust on September 1, 2024 and sell it today you would earn a total of 9,400 from holding Smithson Investment Trust or generate 6.7% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Smithson Investment Trust vs. ImmuPharma PLC
Performance |
| Timeline |
| Smithson Investment Trust |
| ImmuPharma PLC |
Smithson Investment and ImmuPharma PLC Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Smithson Investment and ImmuPharma PLC
The main advantage of trading using opposite Smithson Investment and ImmuPharma PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Smithson Investment position performs unexpectedly, ImmuPharma PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ImmuPharma PLC will offset losses from the drop in ImmuPharma PLC's long position.| Smithson Investment vs. Toyota Motor Corp | Smithson Investment vs. SoftBank Group Corp | Smithson Investment vs. OTP Bank Nyrt | Smithson Investment vs. Las Vegas Sands |
| ImmuPharma PLC vs. Livermore Investments Group | ImmuPharma PLC vs. GlobalData PLC | ImmuPharma PLC vs. The Investment | ImmuPharma PLC vs. Smithson Investment Trust |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Premium Stories module to follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |